ARVN
ARVINAS, INC.
Company overview
- Market capitalization
- $491.05M
- Employees
- 246
- Latest publication
- 2026-09-29
About ARVINAS, INC.
Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. It is also developing clinical development programs , including ARV-102, a leucine-rich repeat kinase 2 (LRRK2) protein for the treatment of neurodegenerative diseases, such as Parkinson's disease and progressive supranuclear palsy; ARV-806, a Kirsten rat sarcoma, G12D protein for the treatment of cancers with the G12D mutation, comprising pancreatic, colorectal, and non-small cell lung cancer; ARV-393, a B-cell lymphoma 6 protein for the treatment of relapsed/refractory non-Hodgkin lymphoma (NHL); ARV-027, a polyglutamine-expanded androgen receptor in skeletal muscle; and vepdegestrant, an estrogen receptor for the treatment of locally advanced or metastatic ER+/HER2- breast cancer. In addition, the company develops Bavdegalutamide (ARV-110) and Luxdegalutamide (ARV-766), investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer. It has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.
Financial statements
Income Quarterly
| Metric | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q4 20232023-12-31 · USD | Q3 20212021-09-30 · USD | Q1 20212021-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 41,900,000USD | 22,400,000USD | 188,800,000USD | 59,200,000USD | 102,400,000USD | -43,100,000USD | 9,300,000USD | 5,500,000USD |
| Gross Profit | 41,900,000USD | 22,400,000USD | 188,800,000USD | 59,200,000USD | 102,400,000USD | -44,800,000USD | 9,300,000USD | 5,500,000USD |
| Research Development | 64,700,000USD | 68,600,000USD | 90,800,000USD | 83,300,000USD | 86,900,000USD | 95,200,000USD | 40,600,000USD | 34,900,000USD |
| Selling General Administrative | 21,600,000USD | 25,300,000USD | 26,600,000USD | 34,100,000USD | 75,800,000USD | 27,000,000USD | 16,000,000USD | 12,300,000USD |
| Total Operating Expenses | 85,700,000USD | 93,900,000USD | 117,400,000USD | 117,400,000USD | 162,700,000USD | 120,500,000USD | 56,600,000USD | 47,200,000USD |
| Operating Income | -43,800,000USD | -71,500,000USD | 71,400,000USD | -58,200,000USD | -60,300,000USD | -165,300,000USD | -47,300,000USD | -41,700,000USD |
| Interest Income | 9,000,000USD | 10,300,000USD | 11,700,000USD | 12,900,000USD | 14,300,000USD | 12,200,000USD | 368,545USD | 450,383USD |
| Net Interest Income | 9,000,000USD | 10,300,000USD | 11,700,000USD | 12,900,000USD | 14,300,000USD | 12,200,000USD | 360,420USD | 434,133USD |
| Income Before Tax | -34,800,000USD | -61,500,000USD | 83,100,000USD | -45,500,000USD | -48,600,000USD | -153,200,000USD | -46,800,000USD | -41,000,000USD |
| Income Tax Expense | 300,000USD | -300,000USD | 200,000USD | -400,000USD | 600,000USD | 1,600,000USD | 227,183USD | 264,056USD |
| Tax Provision | 300,000USD | -300,000USD | 200,000USD | -400,000USD | 600,000USD | 1,600,000USD | — | — |
| Net Income | -35,100,000USD | -61,200,000USD | 82,900,000USD | -45,100,000USD | -49,200,000USD | -154,800,000USD | -46,800,000USD | -41,000,000USD |
| Net Income From Continuing Ops | -35,100,000USD | -61,200,000USD | 82,900,000USD | -45,100,000USD | -49,200,000USD | -154,800,000USD | -46,751,752USD | -40,964,291USD |
| Ebit | -34,800,000USD | -61,500,000USD | 83,100,000USD | -45,500,000USD | -48,600,000USD | -153,200,000USD | -46,791,875USD | -41,700,000USD |
| Ebitda | -34,000,000USD | -60,100,000USD | 84,400,000USD | -43,900,000USD | -47,500,000USD | -151,500,000USD | -45,591,875USD | -40,600,000USD |
| Depreciation And Amortization | 800,000USD | 1,400,000USD | 1,300,000USD | 1,600,000USD | 1,100,000USD | 1,700,000USD | 1,200,000USD | 1,100,000USD |
| Reconciled Depreciation | 1,300,000USD | 1,400,000USD | 1,300,000USD | 1,600,000USD | 1,600,000USD | 1,700,000USD | 1,512,806USD | 1,453,150USD |
| Total Other Income Expense Net | 9,000,000USD | 10,000,000USD | 11,700,000USD | 12,700,000USD | 11,700,000USD | 12,100,000USD | 500,000USD | 700,000USD |
| Cost Of Revenue | — | — | — | 1,600,000USD | — | 1,700,000USD | — | — |
| Unclassified Operating Expenses | — | — | — | — | — | -1,700,000USD | — | — |
| Interest Expense | — | — | — | — | — | 7,100,000USD | 8,125USD | 16,250USD |
| Non Operating Income Net Other | — | — | — | — | — | — | 587,603USD | 698,189USD |
| Net Income Applicable To Common Shares | — | — | — | — | — | — | -46,751,752USD | -40,964,291USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 263,400,000USD | 78,500,000USD | 131,400,000USD | 46,700,000USD | 21,801,777USD | 42,976,478USD | 7,578,876USD | 6,669,024USD |
| Cost Of Revenue | 6,600,000USD | 6,700,000USD | 8,199,999USD | 6,000,000USD | — | — | 31,992,000USD | 22,876,000USD |
| Gross Profit | 263,400,000USD | 78,500,000USD | 131,400,000USD | 46,700,000USD | 21,801,777USD | 42,976,478USD | 7,578,876USD | 6,669,024USD |
| Research Development | 348,200,000USD | 379,700,000USD | 315,000,000USD | 180,400,000USD | 108,355,853USD | 67,193,830USD | 28,792,902USD | 19,942,194USD |
| Selling General Administrative | 165,400,000USD | 100,300,000USD | 79,600,000USD | 61,600,000USD | 38,303,401USD | 27,307,162USD | 3,546,241USD | 3,196,250USD |
| Total Operating Expenses | 513,600,000USD | 480,000,000USD | 394,600,000USD | 242,000,000USD | 146,659,254USD | 94,500,992USD | 32,339,143USD | 23,138,444USD |
| Operating Income | -250,200,000USD | -401,500,000USD | -263,200,000USD | -195,300,000USD | -124,857,477USD | -51,524,514USD | -24,760,267USD | -16,469,420USD |
| Interest Income | 54,800,000USD | 32,300,000USD | 12,200,000USD | 1,900,000USD | 3,585,852USD | 4,557,260USD | 201,388USD | 427,773USD |
| Net Interest Income | 54,800,000USD | 32,300,000USD | 12,200,000USD | 1,800,000USD | 3,520,852USD | 4,471,691USD | 151,031USD | 360,369USD |
| Income Before Tax | -198,300,000USD | -366,400,000USD | -251,000,000USD | -191,000,000USD | -119,332,064USD | -70,292,227USD | -24,049,206USD | -14,438,051USD |
| Income Tax Expense | 600,000USD | 900,000USD | 20,900,000USD | -7,800,000USD | -7,545,358USD | -8,160,189USD | 604,516USD | -87,408USD |
| Tax Provision | 600,000USD | 10,100,000USD | 20,900,000USD | 0USD | 0USD | — | 0USD | -87,408USD |
| Net Income | -198,900,000USD | -367,300,000USD | -271,900,000USD | -183,200,000USD | -111,786,706USD | -62,132,038USD | -24,049,206USD | -14,350,643USD |
| Net Income From Continuing Ops | -198,900,000USD | -295,400,000USD | -282,500,000USD | -191,000,000USD | -119,332,064USD | -70,292,227USD | -24,049,206USD | -14,350,643USD |
| Ebit | -198,300,000USD | -366,400,000USD | -263,200,000USD | -195,300,000USD | -124,857,477USD | -51,524,514USD | -23,998,848USD | -14,370,651USD |
| Ebitda | -191,700,000USD | -359,700,000USD | -255,000,000USD | -189,300,000USD | -120,832,971USD | -49,271,612USD | -23,651,453USD | -13,934,322USD |
| Depreciation And Amortization | 6,600,000USD | 6,700,000USD | 8,200,000USD | 6,000,000USD | 4,024,506USD | 2,252,902USD | 347,395USD | 436,329USD |
| Reconciled Depreciation | 6,600,000USD | 7,100,000USD | 8,200,000USD | 6,000,000USD | 4,024,506USD | 2,252,902USD | 347,395USD | — |
| Total Other Income Expense Net | 51,900,000USD | 35,100,000USD | 12,200,000USD | 4,300,000USD | 5,525,413USD | -18,767,713USD | 711,061USD | 2,031,369USD |
| Interest Expense | — | — | 12,000,000USD | 100,000USD | 65,000USD | 85,569USD | 50,357USD | 67,404USD |
| Non Operating Income Net Other | — | — | 1,600,000USD | 4,400,000USD | 5,590,413USD | -18,682,144USD | — | — |
| Net Income Applicable To Common Shares | — | — | -282,500,000USD | -191,000,000USD | -119,332,064USD | -70,292,227USD | -28,619,637USD | -12,353,623USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 647,500,000USD | 717,900,000USD | 844,300,000USD | 909,300,000USD | 1,001,100,000USD | 1,091,400,000USD | 1,167,100,000USD | 1,279,600,000USD |
| Other Current Assets | 9,400,000USD | 8,900,000USD | 11,900,000USD | 17,200,000USD | 17,000,000USD | 14,200,000USD | 13,100,000USD | 18,000,000USD |
| Total Liab | 260,700,000USD | 284,100,000USD | 279,900,000USD | 300,000,000USD | 341,000,000USD | 529,700,000USD | 581,100,000USD | 679,500,000USD |
| Total Stockholder Equity | 386,800,000USD | 433,800,000USD | 564,400,000USD | 609,300,000USD | 660,100,000USD | 561,700,000USD | 586,000,000USD | 600,100,000USD |
| Other Current Liab | 30,900,000USD | 45,100,000USD | 37,500,000USD | 33,200,000USD | 41,200,000USD | 55,200,000USD | 54,100,000USD | 51,500,000USD |
| Common Stock | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD |
| Capital Stock | 100,000USD | 0USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 0USD |
| Retained Earnings | -1,670,000,000USD | -1,612,400,000USD | -1,545,000,000USD | -1,509,900,000USD | -1,448,700,000USD | -1,531,600,000USD | -1,486,500,000USD | -1,437,300,000USD |
| Other Assets | 1USD | — | — | — | — | — | — | 1USD |
| Cash | 87,300,000USD | 142,900,000USD | 101,500,000USD | 114,900,000USD | 81,000,000USD | 100,500,000USD | 85,200,000USD | 154,800,000USD |
| Cash And Short Term Investments | 614,900,000USD | 685,400,000USD | 787,600,000USD | 861,200,000USD | 954,300,000USD | 1,039,400,000USD | 1,121,600,000USD | 1,228,700,000USD |
| Total Current Assets | 630,700,000USD | 700,700,000USD | 826,300,000USD | 889,500,000USD | 979,700,000USD | 1,067,300,000USD | 1,149,500,000USD | 1,256,700,000USD |
| Total Current Liabilities | 115,900,000USD | 142,500,000USD | 144,900,000USD | 157,800,000USD | 214,000,000USD | 229,800,000USD | 275,900,000USD | 347,200,000USD |
| Current Deferred Revenue | 51,800,000USD | 71,300,000USD | 87,700,000USD | 102,900,000USD | 141,000,000USD | 156,200,000USD | 199,200,000USD | 267,900,000USD |
| Net Debt | -78,700,000USD | -134,000,000USD | -92,000,000USD | -105,000,000USD | -70,500,000USD | -90,800,000USD | -83,700,000USD | -152,700,000USD |
| Short Term Debt | 2,000,000USD | 1,700,000USD | 1,900,000USD | 1,800,000USD | 1,900,000USD | 1,800,000USD | 800,000USD | 1,200,000USD |
| Short Long Term Debt Total | 8,600,000USD | 8,900,000USD | 9,500,000USD | 9,900,000USD | 10,500,000USD | 9,700,000USD | 1,500,000USD | 2,100,000USD |
| Long Term Debt | 300,000USD | 400,000USD | 400,000USD | 500,000USD | 500,000USD | 600,000USD | 600,000USD | 700,000USD |
| Short Term Investments | 527,600,000USD | 542,500,000USD | 686,100,000USD | 746,300,000USD | 873,300,000USD | 938,900,000USD | 1,036,400,000USD | 1,073,900,000USD |
| Net Receivables | 6,400,000USD | 6,400,000USD | 26,800,000USD | 11,100,000USD | 8,400,000USD | 13,700,000USD | 14,800,000USD | 10,000,000USD |
| Accounts Payable | 31,200,000USD | 24,400,000USD | 17,800,000USD | 16,600,000USD | 26,400,000USD | 13,400,000USD | 17,700,000USD | 23,200,000USD |
| Property Plant Equipment Net | 13,300,000USD | 13,400,000USD | 14,100,000USD | 15,400,000USD | 16,600,000USD | 16,000,000USD | 7,800,000USD | 11,300,000USD |
| Property Plant Equipment Gross | 41,800,000USD | 41,600,000USD | 41,600,000USD | 42,100,000USD | 42,500,000USD | 41,600,000USD | 32,300,000USD | 34,700,000USD |
| Accumulated Other Comprehensive Income | -400,000USD | 1,200,000USD | 1,400,000USD | 1,000,000USD | 1,500,000USD | 1,000,000USD | 4,100,000USD | -3,800,000USD |
| Common Stock Shares Outstanding | 64,000,000shares | 64,900,000shares | 72,900,000shares | 73,000,000shares | 72,700,000shares | 72,100,000shares | 72,100,000shares | 71,900,000shares |
| Non Current Assets Total | 16,799,999USD | 17,200,000USD | 18,000,000USD | 19,800,000USD | 21,400,000USD | 24,100,000USD | 17,600,000USD | 22,900,000USD |
| Non Current Liabilities Total | 144,799,999USD | 141,600,000USD | 134,999,999USD | 142,200,000USD | 127,000,000USD | 299,900,000USD | 305,200,000USD | 332,300,000USD |
| Non Currrent Assets Other | 3,499,999USD | 3,800,000USD | 3,900,000USD | 4,400,000USD | 4,800,000USD | 8,100,000USD | 9,800,000USD | 11,600,000USD |
| Net Working Capital | 514,800,000USD | 558,200,000USD | 681,400,000USD | 731,700,000USD | 765,700,000USD | 837,500,000USD | 873,600,000USD | 909,500,000USD |
| Unclassified Non Current Liabilities | 144,499,999USD | 141,100,000USD | 134,599,999USD | 141,700,000USD | 126,500,000USD | 299,200,000USD | 304,600,000USD | 331,500,000USD |
| Unclassified Equity | 2,057,000,000USD | 2,044,900,000USD | 2,107,800,000USD | 2,118,000,000USD | 2,107,100,000USD | 2,092,100,000USD | 2,068,200,000USD | 2,041,100,000USD |
| Non Current Liabilities Other | — | 100,000USD | — | — | — | 100,000USD | — | 100,000USD |
| Unclassified Current Liabilities | — | — | — | 3,300,000USD | 3,500,000USD | 3,200,000USD | 4,100,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 717,900,000USD | 1,091,400,000USD | 1,304,600,000USD | 1,268,800,000USD | 1,581,600,000USD | 717,400,000USD | 301,641,426USD | 199,281,575USD |
| Other Current Assets | 8,900,000USD | 14,200,000USD | 12,000,000USD | 26,900,000USD | 24,200,000USD | 6,100,000USD | 3,727,294USD | 2,818,286USD |
| Total Liab | 284,100,000USD | 529,700,000USD | 644,600,000USD | 703,900,000USD | 799,900,000USD | 75,200,000USD | 74,955,145USD | 62,614,592USD |
| Total Stockholder Equity | 433,800,000USD | 561,700,000USD | 660,000,000USD | 564,900,000USD | 781,700,000USD | 642,200,000USD | 226,686,281USD | 136,666,983USD |
| Other Current Liab | 45,100,000USD | 55,200,000USD | 73,700,000USD | 58,700,000USD | 23,100,000USD | 18,900,000USD | 7,602,904USD | 4,001,276USD |
| Common Stock | 100,000USD | 100,000USD | 100,000USD | 100,000USD | — | 48,455USD | 38,461USD | 31,236USD |
| Capital Stock | 0USD | 100,000USD | 100,000USD | 100,000USD | 0USD | 48,455USD | 38,461USD | 31,236USD |
| Retained Earnings | -1,612,400,000USD | -1,531,600,000USD | -1,332,700,000USD | -965,400,000USD | -682,900,000USD | -491,900,000USD | -372,556,846USD | -302,264,619USD |
| Cash | 142,900,000USD | 100,500,000USD | 311,700,000USD | 81,300,000USD | 108,300,000USD | 588,400,000USD | 9,211,057USD | 3,190,056USD |
| Cash And Short Term Investments | 685,400,000USD | 1,039,400,000USD | 1,261,000,000USD | 1,205,300,000USD | 1,502,600,000USD | 688,600,000USD | 280,872,513USD | 187,827,696USD |
| Total Current Assets | 700,700,000USD | 1,067,300,000USD | 1,280,200,000USD | 1,240,200,000USD | 1,552,500,000USD | 703,100,000USD | 290,880,635USD | 195,677,779USD |
| Total Current Liabilities | 142,500,000USD | 229,800,000USD | 257,100,000USD | 295,100,000USD | 261,700,000USD | 49,200,000USD | 32,813,152USD | 22,979,878USD |
| Current Deferred Revenue | 71,300,000USD | 156,200,000USD | 163,000,000USD | 218,600,000USD | 206,200,000USD | 22,200,000USD | 19,979,525USD | 16,065,957USD |
| Net Debt | -134,000,000USD | -90,800,000USD | -308,500,000USD | -75,800,000USD | -103,300,000USD | -584,300,000USD | -4,823,050USD | -1,035,595USD |
| Short Term Debt | 1,700,000USD | 1,800,000USD | 1,900,000USD | 1,800,000USD | 1,100,000USD | 1,000,000USD | 673,896USD | 154,461USD |
| Short Long Term Debt Total | 8,900,000USD | 9,700,000USD | 3,200,000USD | 5,500,000USD | 5,000,000USD | 4,100,000USD | 4,388,007USD | 2,154,461USD |
| Long Term Debt | 400,000USD | 600,000USD | 800,000USD | 1,000,000USD | 1,000,000USD | 2,000,000USD | 2,000,000USD | 2,000,000USD |
| Short Term Investments | 542,500,000USD | 938,900,000USD | 949,300,000USD | 1,124,000,000USD | 1,394,300,000USD | 100,200,000USD | 271,661,456USD | 184,637,640USD |
| Net Receivables | 6,400,000USD | 13,700,000USD | 7,200,000USD | 8,000,000USD | 25,700,000USD | 8,400,000USD | 6,280,828USD | 5,031,797USD |
| Accounts Payable | 24,400,000USD | 13,400,000USD | 17,800,000USD | 5,700,000USD | 31,300,000USD | 7,100,000USD | 4,556,827USD | 2,758,184USD |
| Property Plant Equipment Net | 13,400,000USD | 16,000,000USD | 14,000,000USD | 17,800,000USD | 16,600,000USD | 14,300,000USD | 10,734,034USD | 3,583,036USD |
| Property Plant Equipment Gross | 41,600,000USD | 41,600,000USD | 35,100,000USD | 17,800,000USD | 16,600,000USD | 14,252,184USD | 10,734,034USD | 3,583,036USD |
| Accumulated Other Comprehensive Income | 1,200,000USD | 1,000,000USD | -3,100,000USD | -19,200,000USD | -4,600,000USD | 600,000USD | 107,576USD | -217,723USD |
| Common Stock Shares Outstanding | 64,900,000shares | 71,900,000shares | 55,500,000shares | 53,200,000shares | 50,000,000shares | 39,534,497shares | 32,927,697shares | 31,628,691shares |
| Non Current Assets Total | 17,200,000USD | 24,100,000USD | 24,400,000USD | 28,600,000USD | 29,100,000USD | 14,300,000USD | 10,760,791USD | 3,603,796USD |
| Non Current Liabilities Total | 141,600,000USD | 299,900,000USD | 387,500,000USD | 408,800,000USD | 538,200,000USD | 26,000,000USD | 42,141,993USD | 39,634,714USD |
| Non Current Liabilities Other | 100,000USD | 100,000USD | — | 407,800,000USD | 537,200,000USD | 24,025,655USD | 40,141,993USD | 150,000USD |
| Non Currrent Assets Other | 3,800,000USD | 8,100,000USD | 10,400,000USD | 10,800,000USD | 12,500,000USD | -2,392,323USD | 26,757USD | 20,760USD |
| Net Working Capital | 558,200,000USD | 837,500,000USD | 1,023,100,000USD | 945,100,000USD | 1,290,800,000USD | 654,002,206USD | 258,067,483USD | 172,697,901USD |
| Unclassified Non Current Liabilities | 141,100,000USD | 299,200,000USD | 386,700,000USD | -405,100,000USD | -534,300,000USD | -22,963,888USD | -38,427,882USD | — |
| Unclassified Equity | 2,044,900,000USD | 2,092,100,000USD | 1,995,600,000USD | 1,549,300,000USD | 1,469,200,000USD | 1,133,403,090USD | 599,058,629USD | 439,086,853USD |
| Unclassified Current Liabilities | — | 3,200,000USD | — | 10,300,000USD | — | — | — | — |
| Other Assets | — | — | 1USD | 10,800,000USD | 100,000USD | 28,777USD | 26,757USD | 20,760USD |
| Other Liab | — | — | — | 405,100,000USD | 534,300,000USD | 22,938,233USD | 38,427,882USD | 37,634,714USD |
| Inventory | — | — | — | 5,500,000USD | 4,500,000USD | — | — | 1USD |
| Net Tangible Assets | — | — | — | 564,900,000USD | 781,700,000USD | 642,257,512USD | 226,686,281USD | 136,666,983USD |
| Unclassified Non Current Assets | — | — | — | -10,800,000USD | — | — | — | — |
| Short Long Term Debt | — | — | — | — | — | — | — | 154,461USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -57,600,000USD | -67,400,000USD | -35,100,000USD | -61,200,000USD | 82,900,000USD | -45,100,000USD | -49,200,000USD | -35,200,000USD |
| Depreciation | 1,100,000USD | 1,200,000USD | 1,300,000USD | 1,400,000USD | 1,300,000USD | 1,600,000USD | 1,600,000USD | 1,700,000USD |
| Stock Based Compensation | 12,100,000USD | 8,500,000USD | 10,200,000USD | 10,300,000USD | 15,000,000USD | 23,300,000USD | 24,700,000USD | 21,600,000USD |
| Other Non Cash Items | 10,700,000USD | -2,200,000USD | 7,499,999USD | -3,100,000USD | -500,000USD | -3,700,000USD | -1,400,000USD | -4,400,000USD |
| Change To Account Receivables | -800,000USD | 20,400,000USD | -15,700,000USD | -2,700,000USD | 5,300,000USD | 1,100,000USD | -4,800,000USD | -2,900,000USD |
| Change In Working Capital | -23,400,000USD | 29,500,000USD | -32,799,999USD | -42,800,000USD | -187,600,000USD | -60,200,000USD | -103,700,000USD | 66,600,000USD |
| Total Cash From Operating Activities | -69,200,000USD | -30,400,000USD | -59,100,000USD | -95,400,000USD | -88,900,000USD | -84,100,000USD | -128,000,000USD | 50,300,000USD |
| Capital Expenditures | -1,300,000USD | -200,000USD | -100,000USD | -1,200,000USD | -400,000USD | -300,000USD | -700,000USD | -700,000USD |
| Free Cash Flow | -70,500,000USD | -30,600,000USD | -59,200,000USD | -96,600,000USD | -89,300,000USD | -84,400,000USD | -128,700,000USD | 49,600,000USD |
| Investments | 15,000,000USD | 146,000,000USD | 63,500,000USD | 128,800,000USD | 69,500,000USD | 98,900,000USD | 50,500,000USD | 13,100,000USD |
| Total Cashflows From Investing Activities | 13,700,000USD | 145,800,000USD | 63,500,000USD | 128,800,000USD | 69,500,000USD | 98,900,000USD | 50,500,000USD | 13,100,000USD |
| Net Borrowings | -100,000USD | -100,000USD | 0USD | 0USD | -100,000USD | -100,000USD | 0USD | — |
| Total Cash From Financing Activities | -100,000USD | -74,000,000USD | -17,800,000USD | 500,000USD | -100,000USD | 500,000USD | 2,400,000USD | 3,400,000USD |
| Change In Cash | -55,600,000USD | 41,400,000USD | -13,400,000USD | 33,900,000USD | -19,500,000USD | 15,300,000USD | -75,100,000USD | 66,800,000USD |
| Begin Period Cash Flow | 142,900,000USD | 101,500,000USD | 114,900,000USD | 81,000,000USD | 100,500,000USD | 85,200,000USD | 160,300,000USD | 93,500,000USD |
| End Period Cash Flow | 87,300,000USD | 142,900,000USD | 101,500,000USD | 114,900,000USD | 81,000,000USD | 100,500,000USD | 85,200,000USD | 160,300,000USD |
| Other Cashflows From Financing Activities | -100,000USD | -74,000,000USD | -17,800,000USD | — | -100,000USD | 600,000USD | 2,400,000USD | 3,500,000USD |
| Unclassified Operating Cash Flow | -12,100,000USD | — | -10,200,000USD | — | — | — | — | — |
| Sale Purchase Of Stock | — | -74,100,000USD | -17,800,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | 74,200,000USD | 17,800,000USD | — | — | — | — | — |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | 100,000USD | 13,800,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -13,100,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -80,800,000USD | -198,900,000USD | -367,300,000USD | -41,480,466USD | -24,049,206USD | -14,350,643USD |
| Depreciation | 5,200,000USD | 6,600,000USD | 6,700,000USD | 706,000USD | 347,395USD | 436,329USD |
| Stock Based Compensation | 44,000,000USD | 88,200,000USD | 71,600,000USD | 11,630,300USD | 245,048USD | 525,586USD |
| Other Non Cash Items | -8,500,000USD | -14,600,000USD | -14,400,000USD | 266,032USD | 362,072USD | 556,416USD |
| Change To Account Receivables | 7,300,000USD | -5,700,000USD | 800,000USD | 22,224,169USD | -25,000,000USD | -578,926USD |
| Change In Working Capital | -233,700,000USD | -140,600,000USD | -44,400,000USD | 12,566,685USD | 28,213,656USD | -5,556,000USD |
| Total Cash From Operating Activities | -273,800,000USD | -259,300,000USD | -347,800,000USD | -16,117,670USD | 5,113,094USD | -19,403,129USD |
| Capital Expenditures | -1,900,000USD | -1,800,000USD | -2,900,000USD | -2,830,661USD | -1,012,428USD | -306,667USD |
| Free Cash Flow | -275,700,000USD | -261,100,000USD | -350,700,000USD | -18,948,331USD | 4,100,666USD | -19,709,796USD |
| Investments | 409,500,000USD | 34,700,000USD | 276,600,000USD | -176,834,699USD | 20,872,112USD | -20,113,549USD |
| Total Cashflows From Investing Activities | 407,600,000USD | 34,700,000USD | 203,500,000USD | -179,665,360USD | 20,872,112USD | -20,113,549USD |
| Net Borrowings | -200,000USD | -400,000USD | 0USD | 1,826,111USD | -161,363USD | -149,739USD |
| Total Cash From Financing Activities | -91,400,000USD | 7,900,000USD | 374,700,000USD | 168,060,695USD | -161,363USD | -149,739USD |
| Sale Purchase Of Stock | -91,900,000USD | 0USD | 0USD | -3,423,589USD | — | — |
| Issuance Of Capital Stock | 0USD | 0USD | 37,100,000USD | 169,583,173USD | — | — |
| Change In Cash | 42,400,000USD | -216,700,000USD | 230,400,000USD | -27,722,335USD | 25,823,843USD | -39,666,417USD |
| Begin Period Cash Flow | 100,500,000USD | 317,200,000USD | 86,800,000USD | 30,912,391USD | 5,088,548USD | 44,754,965USD |
| End Period Cash Flow | 142,900,000USD | 100,500,000USD | 317,200,000USD | 3,190,056USD | 30,912,391USD | 5,088,548USD |
| Other Cashflows From Financing Activities | -91,400,000USD | 8,300,000USD | -12,500,000USD | 51,651,411USD | 20,872,112USD | -20,113,549USD |
| Unclassified Financing Cash Flow | 92,100,000USD | — | 387,200,000USD | 178,505,352USD | -20,872,112USD | 20,113,549USD |
| Other Cashflows From Investing Activities | — | 100,000USD | — | -176,834,699USD | 21,884,540USD | -50,000USD |
| Unclassified Investing Cash Flow | — | 1,700,000USD | -70,200,000USD | 176,834,699USD | -20,872,112USD | — |
| Change To Inventory | — | — | — | -3,261,557USD | 2,262,011USD | — |
| Change To Liabilities | — | — | — | 2,457,503USD | 50,951,645USD | -5,392,319USD |
| Dividends Paid | — | — | — | -60,498,590USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | -27,722,335USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | -1,014,817USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.